Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,26 USD | +5,00% | -5,97% | +50,27% |
Vakgebied
Aantal werknemers: 93
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 01-01-10 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 01-09-18 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 01-01-17 |
Chief Tech/Sci/R&D Officer | - | 01-08-23 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-11-20 |
Murray Stewart
BRD | Director/Board Member | 63 | 29-03-19 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | - | 26-10-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01-07-18 |
David McGirr
BRD | Director/Board Member | 69 | 01-09-17 |
Paula Ragan
FOU | Founder | 54 | 01-01-10 |
Gary Bridger
BRD | Director/Board Member | 61 | 01-10-18 |
Alison Lawton
BRD | Director/Board Member | 62 | 05-10-20 |
Bill Aliski
BRD | Director/Board Member | 75 | 18-09-19 |
Director/Board Member | 62 | 14-10-21 | |
Murray Stewart
BRD | Director/Board Member | 63 | 29-03-19 |
R. Woods
BRD | Director/Board Member | 57 | 16-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 167 937 781 | 162 995 043 ( 97,06 %) | 0 | 97,06 % |
Bedrijfsgegevens
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,27% | 212 mln. | |
-1,42% | 41,52 mld. | |
+42,15% | 39,9 mld. | |
+1,97% | 38,83 mld. | |
-14,19% | 26,05 mld. | |
+1,82% | 23,78 mld. | |
-24,55% | 18,26 mld. | |
-4,07% | 11,65 mld. | |
+21,36% | 11,53 mld. | |
+8,20% | 11,2 mld. |
- Beurs
- Aandelen
- Koers XFOR
- Onderneming X4 Pharmaceuticals, Inc.